Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To assess the safety of Hydroxytite (Crystalys) in subjects who received subdermal or deep-dermal injections | Adverse events or Serious adverse events, Injection site reactions. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Performance | To give a score, using the LRS, to Hydroxytite treatment compared to patient's baseline | 6 months |
| Performance | To give a score, using the Global Aesthetic Improvement Scale (GAIS), to Hydroxytite treatment compared to patient's baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Patient declines to participate in the study
Not provided
Not provided
Not provided
All patients treated with Hydroxytite, above the age of 18
Not provided
Not provided
Not provided
Not provided
| 6 months |